GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (FRA:NNFN) » Definitions » Cyclically Adjusted PS Ratio

MannKind (FRA:NNFN) Cyclically Adjusted PS Ratio : (As of May. 09, 2024)


View and export this data going back to . Start your Free Trial

What is MannKind Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MannKind Cyclically Adjusted PS Ratio Historical Data

The historical data trend for MannKind's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Cyclically Adjusted PS Ratio Chart

MannKind Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.14 5.41 7.38 8.54 5.62

MannKind Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.54 6.39 6.43 5.62 -

Competitive Comparison of MannKind's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, MannKind's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MannKind's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MannKind's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MannKind's Cyclically Adjusted PS Ratio falls into.



MannKind Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

MannKind's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, MannKind's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.188/129.4194*129.4194
=0.188

Current CPI (Mar. 2024) = 129.4194.

MannKind Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 1.498 101.861 1.903
201612 0.123 101.863 0.156
201703 0.029 102.862 0.036
201706 0.019 103.349 0.024
201709 0.016 104.136 0.020
201712 0.033 104.011 0.041
201803 0.023 105.290 0.028
201806 0.024 106.317 0.029
201809 0.025 106.507 0.030
201812 0.087 105.998 0.106
201903 0.082 107.251 0.099
201906 0.071 108.070 0.085
201909 0.066 108.329 0.079
201912 0.070 108.420 0.084
202003 0.069 108.902 0.082
202006 0.063 108.767 0.075
202009 0.057 109.815 0.067
202012 0.065 109.897 0.077
202103 0.059 111.754 0.068
202106 0.078 114.631 0.088
202109 0.076 115.734 0.085
202112 0.044 117.630 0.048
202203 0.043 121.301 0.046
202206 0.070 125.017 0.072
202209 0.128 125.227 0.132
202212 0.129 125.222 0.133
202303 0.144 127.348 0.146
202306 0.169 128.729 0.170
202309 0.148 129.860 0.147
202312 0.199 129.419 0.199
202403 0.188 129.419 0.188

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MannKind  (FRA:NNFN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


MannKind Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of MannKind's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MannKind (FRA:NNFN) Business Description

Industry
Traded in Other Exchanges
Address
1 Casper Street, Danbury, CT, USA, 06810
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind (FRA:NNFN) Headlines

No Headlines